747
Participants
Start Date
September 30, 2004
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
Carbidopa/levodopa/entacapone
Carbidopa/Levodopa/Entacapone 12.5/50/200 mg and 25/100/200 mg capsules.
Immediate release carbidopa/levodopa
Immediate release carbidopa/levodopa 12.5/50 mg and 25/100 mg capsules.
Mount Sinai School of Medicine, New York
Parkinson's Disease and Movement Disorders Center of Long Island, Commack
Parkinson's Disease and Movement Disorder Center of Albany Medical, Albany
University of Rochester, Rochester
Pennsylvania Neurology Institute, Philadelphia
Duke University Medical Center Movement Disorders Center, Durham
Novartis Investigative Site, Madrid
Wesley Woods Health Center, Atlanta
Medical College of Georgia, Augusta
University of Miami, Miami
Parkinson's Disease and Movement Disorder Center, Boca Raton
University of South Florida, Tampa
Charlotte Neurological Service, Port Charlotte
University of Alabama at Birmingham, Birmingham
Semmes-Murphey Clinic, Memphis
Clinical Neuroscience Center, Southfield
Wisconsin Institute for Neurologic and Sleep Disorders, Milwaukee
Northwestern University Medical School, Chicago
Rush University Medical Center, Chicago
Landon Center on Aging, Kansas City
Ochsner Clinic Foundation, New Orleans
Baylor College of Medicine, Parkinson's Disease Center, Houston
Mayo Clinic, Scottsdale
Keck School of Medicine, Division of Movement Disorders, Los Angeles
Coastal Neurological Medical Group, La Jolla
The Parkinson's Institute, Sunnyvale
Reed Neurological Research Center, Los Angeles
Molecular NeuroImaging, LLC, New Haven
Boston University School of Medicine, Boston
Columbia University, Neurological Institute, New York
NeuroHealth, Inc., Warwick
University of Texas Southwestern Medical Center at Dallas, Dallas
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Bruges
Novartis Investigative Site, Edmonton
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Kuopio
Novartis Investigative Site, Mikkeli
Novartis Investigative Site, Oulu
Novartis Investigative Site, Pori
Novartis Investigative Site, Lille
Novartis Investigative Site, Nantes
Novartis Investigative Site, Paris
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Berlin
Novartis Investigative Site, Bochum
Novartis Investigative Site, Dresden
Novartis Investigative Site, Marburg
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Ioannina
Novartis Investigative Site, Thessaloniki
Novartis Investigative Site, Catania
Novartis Investigative Site, Chieti Scalo
Novartis Investigative Site, Lido di Camaiore
Novartis Investigative Site, Napoli
Novartis Investigative Site, Pozzilli
Novartis Investigative Site, Roma
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Jönköping
Novartis Investigative Site, Linköping
Novartis Investigative Site, Norrköping
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Zurich
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Glasgow
Novartis Investigative Site, London
Novartis Investigative Site, Newcastle upon Tyne
Lead Sponsor
Orion Corporation, Orion Pharma
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY